Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Acquaviva

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
JAMA Network Open|April 23, 2024
Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 PandemicZaba Valtuille, Eric Acquaviva, Vincent Trebossen, et al.
Molecular Psychiatry|February 7, 2023
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysisPierre Ellul, Isabelle Melki, Stephanie Antoun, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 24, 2021
Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trialDiane Purper-Ouakil, Hilario Blasco-Fontecilla, Tomas Ros, et al.
Frontiers in Psychiatry|February 5, 2024
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHDAnna Kaiser, Pascal M Aggensteiner, Hilario Blasco Fontecilla, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
JAMA Network Open|April 23, 2024
Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 PandemicZaba Valtuille, Eric Acquaviva, Vincent Trebossen, et al.
Molecular Psychiatry|February 7, 2023
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysisPierre Ellul, Isabelle Melki, Stephanie Antoun, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 24, 2021
Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trialDiane Purper-Ouakil, Hilario Blasco-Fontecilla, Tomas Ros, et al.
Frontiers in Psychiatry|February 5, 2024
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHDAnna Kaiser, Pascal M Aggensteiner, Hilario Blasco Fontecilla, et al.
Pageof 4